Analyst Recommendations

Oppenheimer analyst issues OUTPERFORM recommendation for LGND on November 3, 2025 12:37PM ET. The previous analyst recommendation was Outperform.LGND was trading at $191.31 at issue of the analyst...

November 3, 2025   LGND -1.53%

BMO Capital analyst issues OUTPERFORM recommendation for DD on November 3, 2025 12:36PM ET. The previous analyst recommendation was Outperform.DD was trading at $81.65 at issue of the...

November 3, 2025   DD 7.47%

Susquehanna analyst issues POSITIVE recommendation for SIMO on November 3, 2025 12:35PM ET. The previous analyst recommendation was Positive.SIMO was trading at $98.11 at issue of the analyst...

November 3, 2025   SIMO -5.05%

Susquehanna analyst issues NEUTRAL recommendation for NET on November 3, 2025 12:32PM ET. The previous analyst recommendation was Neutral.NET was trading at $253.3 at issue of the analyst...

November 3, 2025   NET -6.12%

Benchmark analyst issues BUY recommendation for CHTR on November 3, 2025 01:08PM ET. The previous analyst recommendation was Buy.CHTR was trading at $233.84 at issue of the analyst...

November 3, 2025   CHTR -0.03%

Morgan Stanley analyst issues OVERWEIGHT recommendation for SCHW on November 3, 2025 01:05PM ET. The previous analyst recommendation was Overweight.SCHW was trading at $94.52 at issue of the...

November 3, 2025   SCHW 0.72%

Roth Capital analyst issues NEUTRAL recommendation for LCII on November 3, 2025 12:58PM ET. The previous analyst recommendation was Neutral.LCII was trading at $103.49 at issue of the...

November 3, 2025   LCII -1.20%

Roth Capital analyst issues BUY recommendation for SXI on November 3, 2025 12:57PM ET. The previous analyst recommendation was Buy.SXI was trading at $233.23 at issue of the...

November 3, 2025   SXI -2.36%

Citigroup analyst issues BUY recommendation for GGAL on November 3, 2025 12:53PM ET. The previous analyst recommendation was Neutral.GGAL was trading at $59.13 at issue of the analyst...

November 3, 2025   GGAL -1.66%

Citigroup analyst issues BUY recommendation for BMA on November 3, 2025 12:52PM ET. The previous analyst recommendation was Neutral.BMA was trading at $90.46 at issue of the analyst...

November 3, 2025   BMA -1.69%